Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells. - Wikidata - awgldk - TriplyDB

Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.

Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.

http://www.wikidata.org/entity/Q34276149

about

Modulation of Autophagy by Sorafenib: Effects on Treatment Response Ephs and Ephrins in malignant gliomas Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma Celecoxib enhances [sorafenib + sildenafil] lethality in cancer cells and reverts platinum chemotherapy resistance Rationally Repurposing Ruxolitinib (Jakafi (®)) as a Solid Tumor Therapeutic Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS Inhibition of Autophagy by Chloroquine Enhances the Antitumor Efficacy of Sorafenib in Glioblastoma.Sorafenib inhibits cell growth but fails to enhance radio- and chemosensitivity of glioblastoma cell lines.

P2860

Q26745320-15FE4313-4413-4AF0-AF56-A76F00F82BE1 Q27015780-6BF4B88B-3352-4ED4-82F3-33B586C444F9 Q34354781-CDA6DADF-1E27-47DC-8C76-73719BF82E7E Q36839023-A9E960D1-2126-4BDC-8FEE-76AE0479E16C Q36995729-349D00C1-52BB-40BD-9621-03906094F41C Q37109457-8AFE063E-7262-4C00-80D9-FB70ED76AFA8 Q38786782-0CDC05BE-9F0C-45A3-9C47-C5525E87DA89 Q39472878-65F03AFF-DD68-4398-AA29-3B44F04E4BBA

P2860

Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.

http://www.wikidata.org/entity/Q34276149

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.

@ast

Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.

@en

Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.

@nl

type

label

Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.

@ast

Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.

@en

Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.

@nl

prefLabel

Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.

@ast

Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.

@en

Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.

@nl

P1433

Q34276149-81001F45-E782-4BEF-98E4-66834F770C1C

P1476

Q34276149-A1720BC1-419D-4744-9734-308088B4B598

P2093

Q34276149-11419519-3C81-4F11-B127-8B9941664014

Q34276149-8F470294-58A2-40FD-9653-6B80FD16BE70

Q34276149-90784E2A-E4D3-41B9-9190-4F428952D09B

Q34276149-F0643416-338C-4152-AAC0-5FED9992B70E

P2860

Q34276149-03CBD12A-F7A7-4AD3-9611-460F299F0F72

Q34276149-11710ADB-29A8-466E-B7AE-9B78254DED04

Q34276149-30C46AD9-3D7E-4785-BC9E-DEDBFA0840E6

Q34276149-325F1C37-0C62-47DB-8A94-42EFAD02F1AF

Q34276149-37B7FA1F-738B-4660-9496-767C1E2B36F3

Q34276149-3A079301-B00A-48C4-8A46-2F2B75F9F5A4

Q34276149-3A3592BB-25FB-41E1-BDE4-3446FAB215C6

Q34276149-3BD3E7C5-26F7-4456-AA3F-68D6F70228C6

Q34276149-40FF71E7-5513-4DEC-99C6-E43DAD94004F

Q34276149-46F6542B-E146-4597-9D10-971E0B17A949

P304

Q34276149-83ECBC79-C236-4874-A0FF-B8737755033D

P31

Q34276149-C82F55DE-AF93-4692-B044-84DA9E3B9794

P356

Q34276149-19225FB9-DFBD-4CB0-9144-97EADAE30F93

P433

Q34276149-0BA4FE38-6056-4707-A6E7-EB5D8C1741FB

P478

Q34276149-8E2FE2AE-F52E-4A73-83C7-E69D5E5ACCFF

P50

Q34276149-A0106496-F193-4F8A-84C3-A67C8D183B9F

P577

Q34276149-315EC496-4EC4-4FDA-A9D3-48FD94F2426F

P698

Q34276149-7CABC61A-1E2E-404F-84A4-79D569146D9B

P932

Q34276149-083A96FB-F411-4C60-AC47-411BC6BC145C

P356

P1433

Journal of Cellular Physiology

P1476

Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.

@en

P2093

Andrew Poklepovic

http://www.w3.org/2001/XMLSchema#string

Hossein A Hamed

http://www.w3.org/2001/XMLSchema#string

Seyedmehrad Tavallai

http://www.w3.org/2001/XMLSchema#string

Steven Grant

http://www.w3.org/2001/XMLSchema#string

P2860

BAY 43-9006: early clinical data in patients with advanced solid malignancies.

A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias

Sorafenib activates CD95 and promotes autophagy and cell death via Src family kinases in gastrointestinal tumor cells.

OSU-03012 interacts with lapatinib to kill brain cancer cells

Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: focus on epidermal growth factor receptor mutation testing and mutation-positive patients.

Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells.

The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stress.

Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240.

Lapatinib and obatoclax kill breast cancer cells through reactive oxygen species-dependent endoplasmic reticulum stress.

Effects of low concentrations of regorafenib and sorafenib on human HCC cell AFP, migration, invasion, and growth in vitro.

P304

131-139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCP.24689

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

230

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24911215

http://www.w3.org/2001/XMLSchema#string

P932

4182138

http://www.w3.org/2001/XMLSchema#string